Skip to main content
Clinical Trials/NCT02144220
NCT02144220
Completed
N/A

Remote Access to Care, Everywhere: Using Telemedicine to Deliver Patient-centered Care to Patients With Parkinson Disease

University of Rochester3 sites in 1 country277 target enrollmentMarch 2014

Overview

Phase
N/A
Intervention
Not specified
Conditions
Parkinson Disease
Sponsor
University of Rochester
Enrollment
277
Locations
3
Primary Endpoint
Feasibility
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The primary objective of this study is to evaluate the feasibility, efficacy and the value of providing care to individuals with Parkinson disease directly into their homes. The specific aims are:

  1. To demonstrate the feasibility of conducting remote evaluations of patients with Parkinson disease nationally;
  2. To measure the impact of remote care on each patient's ability to improve his or her quality of life (QoL) and better manage his or her Parkinson disease; and
  3. To assess the long-term acceptability to patients in receiving ongoing care remotely via telemedicine.
Registry
clinicaltrials.gov
Start Date
March 2014
End Date
October 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ray Dorsey

Professor

University of Rochester

Eligibility Criteria

Inclusion Criteria

  • Age greater than 30
  • Self reported diagnosis of idiopathic Parkinson disease
  • Ability to converse in English
  • Ability and willingness to provide informed consent and complete study requirements
  • Access to a non-public computer or similar devices with broadband internet.
  • Located in New York, Maryland, Delaware, California, or Florida at time of virtual visit (or veterans with Parkinson disease anywhere in the U.S.)

Exclusion Criteria

  • Any condition (e.g.prominent psychosis) that in the investigator's or coordinator's judgment would preclude participation.
  • Concurrent enrollment in another telemedicine study.

Outcomes

Primary Outcomes

Feasibility

Time Frame: 6 months

The percent of telemedicine visits completed as scheduled. (Goal \>80%)

Change in Quality of Life as Measured by the PDQ-39 Assessment Tool

Time Frame: Baseline and 6 months

The impact on Quality of life (QoL) as measured by the change in PDQ-39 score from baseline to 6 months. The PDQ-39 is a 39-item self-report questionnaire, which assesses Parkinson's disease-specific health related quality over the last month. 5-point ordinal scoring system: 0 = never, 1 = occasionally, 2 = sometimes, 3 = often, 4 = always. Each dimension total score range from 0 (never have difficulty) to 100 (always have difficulty). Lower scores reflect better quality of life.

Secondary Outcomes

  • Percentage of Patients Who Felt That the Recommendations Improved Their Health(6 months)
  • Acceptability(6 months)
  • Feasibility (Descriptive)(6 months)

Study Sites (3)

Loading locations...

Similar Trials